Validation of prognostic indices in Egyptian Budd-Chiari syndrome patients: A single-center study

Table 1 Factors related to the one-year survival

	Alive (n = 135)	Dead (n = 59)	χ2/t	P value
	n (%)	n (%)
Age in years, mean ± SD	28.6 ± 8.47	29.22 ± 10.01	0.44	0.66
Gender
Male	53 (39.3)	30 (50.8)	2.25	0.13
Female	82 (60.7)	29 (49.2)
Genital/oral ulcer	2 (1.5)	6 (10.2)	7.84	0.01
History of DVT	13 (9.6)	17 (28.8)	11.56	0.001
Use of OCP1	15 (18.3)	11 (37.9)	5.25	0.02
Presentation
Acute/subacute	31 (23)	28 (47.5)	11.64	0.001
Chronic	104 (77)	31 (52.5)
Jaundice	45 (33.3)	40 (67.8)	19.81	< 0.001
Hepatic encephalopathy	14 (10.4)	24 (40.7)	23.94	< 0.001
Ascites	110 (81.5)	56 (94.9)	6.00	0.01
Ascites score2
1	26 (19.3)	3 (5.1)	51.38	< 0.001
2	89 (65.9)	17 (28.8)
3	20 (14.8)	39 (66.1)
IVC (occluded/attenuated/web)	16 (11.9)	16 (27.1)	6.95	0.01
PV thrombosis	1 (0.7)	7 (11.9)	12.85	< 0.001
Total bilirubin, mean ± SD	2.15 ± 1.40	5.05 ± 4.93	4.44	< 0.001
Direct bilirubin, mean ± SD	0.90 ± 0.80	2.59 ± 2.94	4.34	< 0.001
Albumin, mean ± SD	3.46 ± 0.63	2.89 ± 0.65	5.75	< 0.001

¹Percentage was calculated among female patients;

²Ascites score was calculated as (1): absent, (2): controlled with sodium restriction or diuretics, or (3): resistant to medical treatment. DVT: Deep venous thrombosis; OCP: Oral contraceptive pills; IVC: Inferior vena cava; PV: Portal vein.